The largest database of trusted experimental protocols

72 protocols using a83 01

1

Fibroblast to Hepatocyte Conversion

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fibroblasts were transduced with four lentiviral vectors coding for selected human hepatic transcription factors (HepaTFs): FOXA2, HNF1α, HNF4α and TBX3 (for lentiviral vectors and transduction see lentivirus procedures section) and cultured in hepatic-specific culture media (Figure 4). Two defined culture media were employed sequentially, endoderm induction medium for 3-5 days (cDMEM supplemented with 4.99mM nicotinamide [Sigma, Cat#N0636], 10ng/ml recombinant human FGF-basic [Peprotech, Cat#100-18B], 20ng/ml recombinant human HGF [Peprotech, Cat#100-39], 0.10% DMSO [Sigma, Cat#D2438], 2μM A-83-01 [Sigma, Cat#SML0788] and 3μM CHIR99021 [Sigma, Cat#SML1046]) followed by hepatic maturation medium until day 13 (cDMEM supplemented with 0.1μM dexamethasone [Sigma, Cat#D8893], ITS (insulin, transferrin, sodium selenite) liquid media supplement 1X [Sigma, Cat#I3146], 640μM N-nitro-Larginine methyl ester hydrochloride [L-NAME; Sigma, Cat#N5751], 20ng/ml recombinant human HGF [Peprotech, Cat#100-39], 20ng/ml recombinant human oncostatin M [Peprotech, Cat#300-10], 0.10% DMSO [Sigma, Cat#D2438], 2μM A-83-01 [Sigma, Cat#SML0788] and 3μM CHIR99021 [Sigma, Cat#SML1046]). Medium was replaced every two days.
Cell morphology was observed along the direct reprogramming protocol with the Nikon ECLIPSE Ts2R-FL microscope and images were acquired using Leica DFC70000T camera.
+ Open protocol
+ Expand
2

Establishing Colorectal Cancer Organoids

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tissue from primary colon tumors and liver metastases was collected from patients who received informed consent for a research specimen protocol approved by the University of Southern California Internal Review Board. Patient tumors were washed in PBS, minced, and digested with 1.5 mg/mL collagenase, 20 μg/mL hyaluronidase, and 10 μM Ly27632. For organoid formation, isolated cells were seeded in Cultrex Basement Membrane Extract Type II (Trevigen, Gaithersburg, MD) and cultured in defined media (described by Sato and Clevers16 (link),35 (link)): Advanced Dulbecco’s modified Eagle’s medium/F12 supplemented with 10% FBS, 1% penicillin/streptomycin, 1% HEPES, 1% GlutaMax, 1 × N2 (Sigma Aldrich, St. Louis, MO), 1× B27 (Sigma Aldrich, St. Louis, MO), 50 ng/ml EGF (Life Technologies, Carlsbad, CA), 100 ng/ml Noggin (Tonbo, San Diego, CA) 1mM N-acetylcysteine (Sigma Aldrich, St. Louis, MO), 10 mM nicotinamide (Sigma Aldrich, St. Louis, MO), 500 nM A 83-01 (EMD Millipore, Billerica, MA), 10 mM SB202190 (Sigma Aldrich, St. Louis, MO), and 0.01mM PGE2 (Sigma Aldrich, St. Louis, MO).
+ Open protocol
+ Expand
3

Culturing and Characterizing Colorectal Cancer Organoids

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Medical Research Council of Hungary (ETT-TUKEB, No 51323-4/2015/EKU) approved the experiments with human samples and informed consent was obtained from the patients. We used the CRC organoid lines established and characterized previously in our research group [22 (link)]. Organoids were cultured in CRC medium containing advanced DMEM/F12 (Gibco), 10 mM HEPES (Merck), penicillin/streptomycin (Gibco), glutamine (Gibco), B27 supplement (Gibco), 1 mM N-Acetyl-Cysteine (Merck), 10 mM Nicotinamide (Merck), 50 ng/mL EGF (Peprotech, London, UK), 10 uM SB202190-Monohydrochloride (Merck) and 500 nM A83-01 (Merck). The Rho kinase inhibitor Y27632 (Merck) was also added for 3 days after passaging to avoid anoikis. Organoids were removed from Matrigel every 5–6 days mechanically, centrifuged at 700× g for 5 min, washed with phosphate-buffered saline (PBS), and digested with TrypLE (Thermo Fisher, Waltham, MA, USA) until organoids were dissociated into cell clusters. Samples were then washed with advanced DMEM/F12 medium and embedded into Matrigel again in a 1:3 ratio. Organoids #1–4 have already been characterized and clinical data of the patients have been published [22 (link),24 (link)].
+ Open protocol
+ Expand
4

Induction of Naïve PSCs into Mesoderm

Check if the same lab product or an alternative is used in the 5 most similar protocols
Naïve PSCs were seeded on Laminin-E8 (0.15 μg/cm 2 iMatrix 511 silk; Nippi) at 2 x 10 4 cells/cm 2 .
The Laminin-E8-coated dish was pre-incubated at 37 °C for at least 30 min. The initial induction medium was composed of Ndiff227, 2 μM A83-01 (ALK4/5/7 inhibitor; Tocris), and 2 μM PD03. The following day, the medium was changed to Ndiff277, 2 μM A83-01, 2 μM PD03, and 1 μg/ml JAK inhibitor I (Merck, Cat. 420099-1 MGCN). The medium was changed again the next day. 10 ng/ml recombinant human BMP4 (R&D systems) was optionally added for 24 hours after the induction.
Cells were dissociated with Accutase for 20-30 min.
+ Open protocol
+ Expand
5

Directed Differentiation of Human PSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Except where specified, reset cells were ʻre-primed' before initiating differentiation. Cells were plated on Geltrex in t2iLGö and after 48 h the medium was changed to E8. Cultures were maintained in E8, passaging at confluence. Lineage-specific differentiation was initiated between 25 and 44 days.
Definitive endoderm was induced according to Loh et al. (2014) (link). Cells were cultured in CDM2 medium (in-house according to Loh et al., 2014) supplemented with 100 ng/ml activin A (produced in-house), 100 nM PI-103 (Bio-Techne, 2930), 3 µM CHIR99021, 10 ng/ml FGF2, 3 ng/ml BMP4 (Peprotech) for 1 day. For the next 2 days the following supplements were applied: 100 ng/ml activin A, 100 nM PI-103, 20 ng/ml FGF2, 250 nM LDN193189.
For lateral mesoderm induction (Loh et al., 2016 (link)), cells were treated with CDM2 supplemented with 30 ng/ml activin A, 40 ng/ml BMP4 (Miltenyi Biotech, 130-098-788), 6 µM CHIR99021, 20 ng/ml FGF2, 100 nM PI-103 for 1 day, then with 1 µM A8301, 30 ng/ml BMP4 and 10 µM XAV939 (Sigma-Aldrich).
For neural differentiation via dual SMAD inhibition (Chambers et al., 2009 (link)), cells were treated with N2B27 medium supplemented with 500 nM LDN193189 (Axon, 1509) and 1 μM A 83-01 (Bio-Techne, 2939) for 10 days, then passaged to plates coated with poly-L-ornithine and laminin and further cultured in N2B27 without supplements.
+ Open protocol
+ Expand
6

Establishment of Pancreatic Cancer Organoids

Check if the same lab product or an alternative is used in the 5 most similar protocols
Between 2014 and 2017, tumor samples were collected from human pancreatic ductal adenocarcinoma cancer (PDAC) patients under IRB12-1108 and IRB13-1149. Samples were obtained from patients undergoing pancreatic resections at The University of Chicago Medicine (UCM) facilities. Tumor samples were digested and established into organoids according to established protocols previously published9 (link). Briefly, organoids were grown and cultured by embedding dissociated tumor cells in growth-factor-reduced (GFR) Matrigel (Corning, 356231) and cultured in complete media (Intesticult [Stemcell Technologies, 6005], A83-01 [0.5 µM, Sigma, SML0788], fibroblast growth-factor 10 [FGF10, 100 ng/ml, Gibco, PHG024], Gastrin I [10 nM, Sigma, 17105-041], N-acetyl-L-cysteine [10 mM, Sigma, A9165], Nicotinamide [10 mM, Sigma, N0636], B27 supplement [1x, Gibco, 17504-044], Primocin [1 mg/ml, InvivoGen, ant-pm-1], and Y-27632 [10.5 μM Tocris, 1254]). Organoids were passaged via mechanical dissociation and TrypLE Express (Fisher Scientific, 12605-010) to single cells before being loaded on to the platform.
+ Open protocol
+ Expand
7

Optimized Embryonic Stem Cell Induction

Check if the same lab product or an alternative is used in the 5 most similar protocols
The ExM induction protocol was modified based on previous reports [38 (link),39 (link)]. Prior to induction, all cell types were brought into the same hypoxic, feeder-free condition on 10 μg/mL Biolaminin 521. For this, nESC were depleted of feeder cells [24 (link)] and prESC were placed in the hypoxic incubator 24 h after plating. After reaching confluency, cells were briefly washed with PBS and incubated in N2B27 medium supplemented with 30 ng/mL ACTIVIN A, 40 ng/mL BMP4 (PeproTech, 120-05ET), 6 μM CHIR99021, 20 ng/mL FGF2 (PeproTech, 100-18B), 100 nM PIK90 (Axon MedChem, 1362), and 1:1000 Penicillin–Streptomycin. After 24 h, following a brief wash with PBS, cells were treated with N2B27 medium supplemented with 1 μM A8301 (Sigma, St. Louis, MO, USA, SML0788), 30 ng/mL BMP4, 1 μM C59 (Axon MedChem, 2287), and 1:1000 Penicillin–Streptomycin for 14 days, with a medium change of every 1–2 days.
+ Open protocol
+ Expand
8

Tonsil Organoid Culture Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The tonsil samples were chopped and washed with Dulbecco's phosphate-buffered saline (D-PBS; Welgene, Daegu, Korea) and then enzymatically digested with 1 mg/mL collagenase II (Gibco) in advanced DMEM/F12 (Gibco) for 2 h at 37 °C. After digestion, isolated cells were embedded in Matrigel (Corning Inc., Corning, NY, USA) in a 48-well plate (SPL Inc., Seongnam, Korea) and incubated at 37 °C for 10 min to polymerize the matrices. Tonsil organoids were cultured in advanced DMEM/F12 supplemented with Antibiotic–Antimycotic, Glutamax (Thermo Fisher Scientific), B27 (Invitrogen, Carlsbad, CA, USA), 10% conditioned media from Cultrex HA-R-spondin1-Fc 293T cells (R&D Systems, Minneapolis, MN, USA), and the following growth factors: 50 ng/mL recombinant murine HGF (Peprotech, Rocky Hill, NJ, USA), 100 ng/mL noggin (ProSpec, St. Paul, MN, USA), 20 nM A83-01 (Sigma), 50 ng/mL human FGF10 (ATGen, Seongnam, Korea), 20 ng/mL human bFGF (Peprotech), 10 μM prostaglandin E2 (BioGems, Westlake Village, CA, USA), and 10 mM nicotinamide (Sigma). For passage, organoids were dissociated by incubation in 0.25% trypsin-EDTA (Invitrogen, Waltham, Massachusetts, USA) every 7–10 days depending on the number and size of organoids. For the first 2 days at every passage, 10 μM Y-27632 (Tocris Biosciences, Bristol, UK) was added to the culture medium.
+ Open protocol
+ Expand
9

Organoid Culture from Intestinal Crypts

Check if the same lab product or an alternative is used in the 5 most similar protocols
For construction of organoids, 200–500 crypts per well were suspended in Matrigel (Corning) as described.58 (link) Complete ENR medium (all components from Thermo Fisher Scientific unless noted) were comprised of advanced DMEM/F12 (Gibco), antibiotic-antimycotic (×100), 1 mM N-acetyl cysteine (Sigma-Aldrich), B27 supplement, N2 supplement, EGF, Noggin (R&D Systems), R-spondin-1-conditioned medium, and Y-27632 (Sigma). Y-27632 was added to the ENR medium for the first 48–72 h of culture only and then removed during the medium change. The ENR medium was replaced every 2 to 3 days. Colon organoids were cultured in the ENR medium supplemented with Wnt3 conditioned media (WENR). Human colon organoids were cultured in WENR medium supplemented with gastrin, nicotinamide, A83-01, and SB202190 (all from Sigma) as described.59 (link) Isolated ISCs and Paneth cells were co-cultured in ENR medium supplemented with Jagged-1 (1 µM; Anaspec). Wnt-C59 (50 µM; Abcam) was used as a porcupine (PORCN) inhibitor. The surface areas of SI and colon organoids were measured microscopically by taking several random non-overlapping photos of organoids in a well using an inverted microscope (Carl Zeiss). Each photo was analyzed using ImageJ software (NIH) and the Zen image program (Carl Zeiss). Organoid perimeters for area measurements were defined manually using automated ImageJ software.
+ Open protocol
+ Expand
10

Hypoxia-Reoxygenation Treatment of HUVECs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human umbilical vein endothelial cells (HUVECs) were purchased from ScienCell Research Laboratories, Inc (Carlsbad, CA). EC medium supplemented with 5% FBS and 1% EC growth supplement was used. Cells were cultured in a humidified 5% CO2 incubator at 37°C and used between the third and sixth passages. Cells were treated with IH for 72 hours (air‐phase set point consisted of a 35‐minute hypoxic period, followed by 25 minutes of reoxygenation [21% O2 and 5% CO2]).21, 22 The medium was changed every 48 hours. Before IH treatment, HUVECs were infected with lentivirus at a multiplicity of infection of 10 for 36 hours. Cells were further cultured for 72 hours after confirming that more than 90% cells were positive for green fluorescent protein. For Smad2/3 inhibition, according to the manufacturer's instructions, cells were treated with smad2/3 inhibitor (12 nmol/L of A83‐01; Sigma‐Aldrich, St. Louis, MO).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!